CAS 1193347-22-6

Spirohexenolide A

CAS : 1193347-22-6

Spirohexenolide A is an inhibitor of human macrophage migration inhibitory factor (hMIF) with a dissociation constant (Kd) of 35.9 μM. It is employed in the study of cellular transport.

Couleur et forme : Solid

Ref: TM-T89526

Spirohexenolide A

CAS : 1193347-22-6

Spirohexenolide A is a potent inhibitor of cancer cell replication. It has been shown to inhibit the growth of various types of cancer cells, including those found in human tumors and urine. This compound works by inhibiting the activity of kinases, which are enzymes that play a key role in cell division and proliferation. Spirohexenolide A is an analog of methotrexate, a chemotherapy drug commonly used to treat cancer. However, unlike methotrexate, spirohexenolide A does not cause significant toxicity or side effects. Studies have also shown that spirohexenolide A can induce apoptosis (programmed cell death) in cancer cells, making it a promising candidate for cancer therapy. Additionally, this compound has been found to be a potent inhibitor of astaxanthin kinase in Chinese hamster ovary cells.

Formule : C₂₅H₂₈O₅

Degré de pureté : Min. 95%

Masse moléculaire : 408.5 g/mol

Ref: 3D-TXB34722